Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when does he expect to receive the outcome of the Prostate Cancer UK-led Transform screening trial.

The Government is partnering with Prostate Cancer UK (PCUK) on the £42 million TRANSFORM screening trial to find the best way to screen men for prostate cancer to find it before it becomes advanced and harder to treat. PCUK is managing the award on behalf of the funders, with the Government contributing £16 million through the National Institute for Health and Care Research (NIHR).

In November 2025, the TRANSFORM trial began recruitment as part of the initial 16,000 men taking part in stage one, from 2025 to 2027, which will test new techniques against the current National Health Service diagnostic pathway. Although the TRANSFORM trial will run for over a decade, there will be multiple points during the trial where new evidence will be generated, with stage 1 due to end in April 2027.

The UK National Screening Committee are working closely with the TRANSFORM trial team and will assess new evidence as it becomes available. This will ensure that prostate cancer policy is kept at the forefront of the Government’s cancer agenda.

The NIHR continues to encourage and welcome applications for research into any aspect of human health and care, including prostate cancer.